Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab

Detalles Bibliográficos
Autores principales: Peragine, Nadia, De Propris, Maria Stefania, Intoppa, Stefania, Milani, Maria Laura, Mariglia, Paola, Mauro, Francesca Romana, Raponi, Sara, Soddu, Stefano, Cuneo, Antonio, Rigolin, Gian Matteo, Del Giudice, Ilaria, Foà, Robin, Guarini, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094098/
https://www.ncbi.nlm.nih.gov/pubmed/33054124
http://dx.doi.org/10.3324/haematol.2020.262071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094098/
https://www.ncbi.nlm.nih.gov/pubmed/33054124
http://dx.doi.org/10.3324/haematol.2020.262071

Ejemplares similares